BackMega Lifesciences Public Company Limited Overview

Mega Lifesciences Public Company Limited Receivables

Mega Lifesciences Public Company Limited's receivables is $3.9B.

Get informed when a big investor buys or sells

+ Follow
Receivables
$3.88B
↑ 13.71% YoYΔ $467.93M vs prior year quarter

Peer trimmed avg / median

Loading

Mega Lifesciences Public Company Limited Receivables History

Loading

Mega Lifesciences Public Company Limited vs. peers: Receivables Comparison

Loading

Mega Lifesciences Public Company Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Mega Lifesciences Public Company Limited (MEGA.BK) FAQ

Mega Lifesciences Public Company Limited's receivables stands at $3.9B as of September 2026. That compares with $3.4B in the prior-year period — up 13.7% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Mega Lifesciences Public Company Limited reported $3.9B in receivables versus $3.4B a year earlier — a 13.7% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $3.4B in the prior-year period — up 13.7% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Mega Lifesciences Public Company Limited's receivables evolved across reporting periods, while the comparison chart places MEGA.BK next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Questions & Answers